__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Management of Pyrexia

This video is intended for patients already prescribed dafrafenib/trametinib and must only be shown to patients prescribed the drug.

 

This is a short video, less than 3 minutes long, which could be valuable to play for your patients taking Tafinlar (daprafenib) + Mekinist (trametinib) to help them understand and manage Pyrexia (fever).

The video covers:

  • What is Pyrexia?
  • How do I know if I have Pyrexia?
  • What should I do?
  • How to manage a fever at home?

For a hard copy of this CD to give to a patient to take home, please order from the webshop.

Rate this content: 
No votes yet
IE212361 | June 2024
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.